Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-08 · accession 0001209191-22-049244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-08 | 2022-09-08 | RLAY | Catinazzo Thomas | CFO | S - Sale+OE | $30.00 | -26.3K | 52.2K | -33% | -$787.7K |
| D | 2022-09-08 | 2022-09-08 | RLAY | Catinazzo Thomas | CFO | M - OptEx | $4.12 | +26.3K | 78.5K | +50% | +$108.2K |
| D | 2022-09-08 | 2022-09-08 | RLAY | Catinazzo Thomas | CFO | M - OptEx | $0.00 | -26.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-08 | S | D | 26,257 | $30.00 | 52,218 | D | — | — | (F2) Includes 45,273 shares underlying restricted stock units. |
| 2 | Common | Common Stock | 2022-09-08 | M | A | 26,257 | $4.12 | 78,475 | D | — | — | (F2) Includes 45,273 shares underlying restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-09-08 | M | D | 26,257 | $0.00 | 0 | D | $4.12 · — to 2028-04-09 | 26,257 Common Stock | (F3) Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |